The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents
Patrick M. Honore,
Aude Mugisha,
Luc Kugener,
Sebastien Redant,
Rachid Attou,
Andrea Gallerani,
David De Bels
Affiliations
Patrick M. Honore
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
Aude Mugisha
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
Luc Kugener
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
Sebastien Redant
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
Rachid Attou
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
Andrea Gallerani
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
David De Bels
ICU Department, Centre Hospitalier Universitaire Brugmann-Brugmann University Hospital
